Growth Hormone Deficiency
Growth hormone deficiency (GHD), also known as hyposomatotropism or pituitary dwarfism, is an endocrine disorder that occurs when the pituitary gland does not produce sufficient amounts of growth hormone (GH). This hormone is essential for growth and development in children and for maintaining various metabolic functions in adults.
While the most visible sign of GHD is short stature, the condition affects far more than just height. It can impact muscle mass, bone density, and overall metabolic health. GHD can be present from birth (congenital) or develop later in life (acquired), and its management typically involves lifelong or long-term hormone replacement therapy.
ไม่มีภาพประกอบ
Key Facts
- Primary Symptom: Significantly short height and delayed physical maturation in children.
- Causes: Can be genetic, idiopathic (unknown cause), or caused by trauma, tumors, and radiation.
- Diagnosis: Confirmed through blood tests and "provocative tests" to measure GH secretion.
- Treatment: Managed with synthetic recombinant human growth hormone (rHGH) injections.
- Adult Impact: Can lead to increased body fat, reduced muscle mass, and poor bone density.
Signs and Symptoms
In Children
In the first few months of life, congenital GHD may not immediately impair growth. However, from the first year through the mid-teens, poor growth velocity is the hallmark of the condition. Children with GHD typically grow at about half the usual rate for their age. This is often accompanied by delayed bone maturation and a delay in the onset of puberty. If left untreated, adult heights may be as short as 120–170 cm (48–65 inches).
Newborns may also exhibit specific signs such as low blood sugar (hypoglycemia) or a small penis size.
In Adults
Adult-onset GHD or untreated childhood GHD manifests through a variety of systemic issues. These include:
- Physical Changes: Increased body fat (particularly central adiposity around the waist), reduced muscle mass and strength, and baldness in men.
- Metabolic Issues: Insulin resistance, high LDL cholesterol levels, and lipid abnormalities.
- Bone and Joint Health: Decreased bone density leading to osteoporosis and potential fibromyalgia syndrome.
- Psychological and Cognitive Effects: Depression, anxiety, social isolation, impaired concentration, and memory loss.
- Cardiovascular Health: Cardiac dysfunction, including a thickened intima media and an accelerated prothrombotic state.
Causes and Risk Factors
GHD occurs when the pituitary gland—a pea-sized gland at the base of the brain—fails to secrete enough growth hormone. The causes are categorized into two main types:
Congenital Causes
Some individuals are born with GHD due to genetic mutations in genes such as GH1, GHRHR, or BTK. It is also associated with congenital syndromes, including:
- Prader-Willi syndrome
- Turner syndrome
- Noonan syndrome
- Septo-optic dysplasia
Acquired Causes
GHD can develop later in life due to external factors that damage the pituitary gland, such as:
- Tumors: Intracranial tumors, particularly craniopharyngiomas.
- Medical Treatment: Radiation therapy for cancers (cranial irradiation).
- Trauma: Head injuries or infections.
- Vascular Issues: Ischemic or hemorrhagic infarction, such as Sheehan syndrome (caused by low blood pressure during childbirth) or pituitary apoplexy.
- Other: Autoimmune inflammation (hypophysitis) or chronic kidney disease.
In approximately one-third of cases, the cause remains idiopathic, meaning no clear cause is identified.
Diagnosis and Classification
Diagnosing GHD requires a combination of physical measurements and hormonal analysis. Doctors use auxologic criteria (body measurements) to track growth velocity and bone age via X-rays.
Blood tests measure levels of IGF-1 (Insulin-like Growth Factor 1) and IGF-2. Because GH is released in pulses, a single blood test is often insufficient. Instead, "provocative tests" are used. These involve administering agents like insulin, arginine, or clonidine to stimulate the pituitary gland, followed by blood draws every 15 minutes to see if GH levels rise.
| Feature | Childhood GHD | Adult GHD |
|---|---|---|
| Primary Indicator | Short stature / Slow growth velocity | Metabolic changes / Reduced quality of life |
| Common Causes | Genetics, Idiopathic, Congenital malformations | Pituitary tumors, Radiation, Trauma |
| Treatment Goal | Attaining normal adult height | Improving muscle mass, bone density, and mood |
| Dosage Frequency | Daily injections | Weekly doses (approx. 25% of pediatric dose) |
Treatment and Prognosis
The standard treatment for GHD is growth hormone replacement therapy. Since 1985, this has been achieved using recombinant human growth hormone (rHGH), a synthetic version produced by genetically engineered bacteria.
Pediatric Treatment
Children receive daily injections into the biceps, thigh, buttocks, or stomach. To prevent lipoatrophy (loss of fat tissue), injection sites must be rotated daily. Treatment typically continues as long as the child is growing. With early intervention, children can often reach a height within the normal range for their family.
Adult Treatment
Adults receive significantly lower doses than children to avoid side effects. Treatment is generally indicated for those with severe deficiency (peak GH response <9mU/litre during an insulin tolerance test) or those already treating other pituitary hormone disorders.
Potential Side Effects
While generally safe, rHGH therapy can cause:
- Joint and muscle pain
- Headaches and nausea
- Fluid retention and carpal tunnel syndrome
- Mild hypertension
- Rarely, benign intracranial hypertension
Frequently Asked Questions
What is the difference between GHD and Laron dwarfism?
In GHD, the body does not produce enough growth hormone. In Laron dwarfism (GH insensitivity), the body produces growth hormone, but the receptors are mutated, meaning the body cannot respond to the hormone.
Can adults start growth hormone treatment to reverse aging?
No. Medical supplementation is not recommended for the natural, age-related decline in growth hormone. It is only indicated for diagnosed adult-onset deficiency.
How is growth hormone administered?
It is administered via daily injections under the skin (subcutaneous) or into the muscle (intramuscular) using insulin syringes, pen injectors, or needle-free systems.
Is growth hormone deficiency hereditary?
It can be. Familial isolated growth hormone deficiency (IGHD) can be inherited as an autosomal recessive, autosomal dominant, or X-linked characteristic.
How expensive is the treatment?
Treatment is costly. In the United States, pediatric treatment can cost between $10,000 and $40,000 per year, while adult treatment in the UK is estimated at 3,000–4,000 GBP annually.